brequinar has been researched along with Cancer of Pancreas in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chaika, NV; Fujii, Y; He, C; Kollala, SS; Mulder, SE; Mullen, NJ; Sharma, S; Shukla, SK; Singh, PK; Sykes, DB; Thakur, R; Wang, D | 1 |
| Beytagh, MC; Bhutkar, A; Colón, CI; Drapkin, BJ; Dyson, NJ; Farago, AF; Hsu, PP; Jacks, T; Lewis, CA; Li, L; Li, Z; Mercer, KL; Muzumdar, MD; Myers, DT; Nabel, CS; Ng, SR; Phat, S; Romero, R; Vander Heiden, MG; Westcott, PMK | 1 |
| Dallaire, B; Gyves, J; Maroun, J; Moore, M; Natale, R; Neidhart, J; Robert, F; Sisk, R | 1 |
1 trial(s) available for brequinar and Cancer of Pancreas
| Article | Year |
|---|---|
Multicenter phase II study of brequinar sodium in patients with advanced gastrointestinal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Biphenyl Compounds; Colorectal Neoplasms; Drugs, Investigational; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Stomach Neoplasms | 1993 |
2 other study(ies) available for brequinar and Cancer of Pancreas
| Article | Year |
|---|---|
ENT1 blockade by CNX-774 overcomes resistance to DHODH inhibition in pancreatic cancer.
Topics: Animals; Dihydroorotate Dehydrogenase; Enzyme Inhibitors; Equilibrative Nucleoside Transporter 1; Mice; Oxidoreductases Acting on CH-CH Group Donors; Pancreatic Neoplasms; Pyrimidine Nucleotides; Pyrimidines | 2023 |
Identification of DHODH as a therapeutic target in small cell lung cancer.
Topics: Adenocarcinoma; Animals; Biphenyl Compounds; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; DCMP Deaminase; Dihydroorotate Dehydrogenase; Disease Progression; Enzyme Inhibitors; Humans; Lung Neoplasms; Mice; Molecular Targeted Therapy; Oxidoreductases Acting on CH-CH Group Donors; Pancreatic Neoplasms; Pyrimidines; Small Cell Lung Carcinoma; Survival Analysis; Xenograft Model Antitumor Assays | 2019 |